Neuralstem signs definitive agreements to sell $10M of units in registered-direct offering

Neuralstem, Inc. (NYSE Amex: CUR) announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant.  The warrants have an exercise price of $3.25 and a term of three years. Neuralstem will receive gross proceeds of $10,000,000.00 before deducting placement agent fees and other offering expenses. The offering is expected to close on June 29, 2010, subject to customary closing conditions.

Neuralstem intends to use the net proceeds from the offering for working capital and general corporate purposes.

The shares are being offered and sold pursuant to a shelf registration statement relating to the offering.  A prospectus supplement relating to the offering of the shares, warrants and shares underlying the warrants will be filed with the SEC.  

Noble Financial Capital Markets acted as the sole placement agent for the offering.

Source:

Neuralstem, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post